COMMUNIQUÉS West-GlobeNewswire

Financière de Tubize - Approbation du dividende
26/04/2025
Approbation du dividende Information réglementée - 25 avril 2025 L’assemblée générale des actionnaires du 25 avril 2025 a approuvé les comptes annuels relatifs à l’exercice social clôturé le 31 décembre 2024, en ce [...]
Hgh X2 Reviews 2025: Dosage ,Side Effects, Cycle (Human Growth Hormone For Muscle Growth) - HGH for Bodybuilding By Crazy Bulk
26/04/2025
New York City, April 26, 2025 (GLOBE NEWSWIRE) -- In bodybuilding, optimal muscle gain, strength, and bodybuilding are surpassed with intense training and strict dieting. For such a bodybuilder looking for a legal, [...]
Mitolyn Reviews 2025 (WARNING) Purple Peel Exploit Scientific Evidence, Complaints & What the Users Says About Mitochondrial Support!
26/04/2025
New York City, April 26, 2025 (GLOBE NEWSWIRE) -- More individuals wish to lose weight, feel more energetic, and become healthier. While most weight loss supplements offer immediate results, they can damage your long- [...]
Gluco6 Reviews (SHOCKING RESULTS) Is This Herbal Formula Control Blood Sugar Effectively or Over Hype?
26/04/2025
LOS ANGELES, April 26, 2025 (GLOBE NEWSWIRE) -- Gluco6 is a natural blood sugar support supplement emerging as a popular choice in the ever-growing market of anti-diabetic supplements. The formula targets some key [...]
VitaSeal Reviews (EXPERT OPINION) Does VitaSeal Really Work For Diabetes or Is It Just Hype? (Pros & Cons)
26/04/2025
MINNEAPOLIS, April 26, 2025 (GLOBE NEWSWIRE) -- VitaSeal is a natural blood sugar control formula that has been receiving much hype lately. The manufacturer claims this supplement is a combination of natural ingredients [...]
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
26/04/2025
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced [...]
Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees
25/04/2025
FLORHAM PARK, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that Nasdaq has notified the Company [...]
Rezolute, Inc. Announces Closing of Underwritten Offering
25/04/2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare [...]
New Data at AACR Annual Meeting Highlights Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Distant Metastasis
25/04/2025
FRIENDSWOOD, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new research intended to improve [...]
Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
25/04/2025
Podium presentation showcases the clinical application of Precise™ MRD SALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision [...]
Prelude Announces Presentations at 2025 AACR Annual Meeting
25/04/2025
Preclinical data elucidating the mechanism of action of PRT3789, Prelude’s first-in-class, highly selective SMARCA2 degrader currently in early clinical development Highlights from Prelude’s efforts to discover and [...]
AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance
25/04/2025
IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the [...]
SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) Announces Halo Spin-Out Distribution for Stockholders of Record as of April 23, 2025
25/04/2025
TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) (NYSE American: BTTR) (the “Company”), a leading global health and wellness company, today [...]
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
25/04/2025
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 Zug, Switzerland, April 25, 2025 – MoonLake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating [...]
Oculis Updates Share Capital
25/04/2025
ZUG, Switzerland, April 25, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company, has issued registered ordinary shares of the Company, each [...]
Spanios and White Lion Capital LLC Announce Strategic Partnership to Accelerate Drug Development
25/04/2025
HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) -- Spanios, a leader in human-derived organoid model systems, is pleased to announce a strategic partnership with White Lion Capital LLC. This collaboration empowers biotech and [...]
Clenbuterol Bodybuilding (Clen) Pills, Clenbuterol Dosage, Clenbuterol, Benefits, Clenbuterol Side Effects, Clenbuterol Cycles, Where to buy Clenbuterol tablet buy, ambroxol, lavizoo (CrazyBulk)
25/04/2025
New York City, April 25, 2025 (GLOBE NEWSWIRE) -- Why Do People Look for Weight Loss Pills? Many people want a leaner body and look for pills to help them achieve this. One such pill is Clenbuterol , which is often used [...]
Tevogen Bio Announces 2025 Annual Meeting
25/04/2025
WARREN, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen Bio” or “Company”) (Nasdaq: TVGN ) today announced that the Company will hold its 2025 annual meeting of stockholders (the “Annual [...]
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
25/04/2025
Gene signatures associated with increased efficacy of micvotabart pelidotin (MICVO) due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders Mouse [...]

Pages